GMAB Latest Headlines

Genmab Ends Early GEN1047 Cancer Trial, Narrowing One Pipeline Bet

at www.tipranks.com (Fri, 24-Jul 12:31 PM)

AbbVie, Genmab announce late-stage trial setback for lymphoma therapy

at seekingalpha.com (Fri, 24-Jul 7:54 AM)

Genmab (GMAB) Receives a Hold from Morgan Stanley

at www.tipranks.com (Thu, 23-Jul 8:57 AM)

Genmab’s TIVDAK Cervical Cancer Trial Update: What a Termination Means for Investors

at www.tipranks.com (Wed, 22-Jul 12:30 PM)

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB) and Immix Biopharma (IMMX)

at www.tipranks.com (Wed, 22-Jul 6:30 AM)

Genmab A/S (0MGB) Receives a Buy from Goldman Sachs

at www.tipranks.com (Wed, 22-Jul 5:53 AM)

Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market

at www.tipranks.com (Mon, 20-Jul 12:31 PM)

Genmab Reports $4.21 Billion in Q2 DARZALEX Sales: U.S. Strength Fuels Global Growth

Market Chameleon (Wed, 15-Jul 9:42 AM)

Genmab Showcases Broad Clinical Advances: Twenty-Three Oncology Abstracts at ASCO and EHA 2026 Highlight Depth, Pipeline Progress

Market Chameleon (Fri, 22-May 9:15 AM)

Orbis Investment Management Now Controls Over 5% of Genmab’s Voting Rights—Why This Major Shareholder Stake Matters

Market Chameleon (Mon, 11-May 7:10 AM)